Giada Bianchi MD

Physician

450 Brookline AveBoston, MA 02215
Phone+1 617-632-3000
Fax+1 617-732-5706

Dr. Bianchi is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bianchi's full profile Already have an account?

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
Universita San RaffaeleClass of 2006

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2012 - 2027
MN State Medical License 2011 - 2012
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2017
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017

Publications & Presentations

PubMed

Elranatamab: A novel B-cell maturation T-cell engager.
Shahrier Hossain, Giada Bianchi
Human Vaccines & Immunotherapeutics. 2026-12-01
Systemic light chain and transthyretin amyloidosis-treatment advancements and future directions.
Giada Bianchi, Vaishali Sanchorawala, Ashutosh Wechalekar, Martha Grogan, Sarah A M Cuddy
Lancet. 2026-08-01
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.
Ashutosh D Wechalekar, Angela Dispenzieri, Vaishali Sanchorawala, Efstathios Kastritis, Divaya Bhutani
Journal of Clinical Oncology. 2026-07-10

Abstracts/Posters

Targeting Myeloma Cell Metabolism Via Disruption of the Lnc-17-92 Transcriptional Program: Druggable New Vulnerability in Multiple Myeloma
Giada Bianchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Phase II Study of Elotuzumab in Combination with Pomalidomide, Bortezomib, and Dexamethasone in Relapsed and Refractory Multiple Myeloma
Giada Bianchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Loss-of-Function of Gabarap Impairs Bortezomib-Induced Anti-Tumor Immunity in Multiple Myeloma: Clinical Application
Giada Bianchi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Special Symposium on ASH-Supported Researchers
60th American Society of Hematology Annual Meeting - 12/3/2018
Special Symposium on ASH-Supported Researchers
60th American Society of Hematology Annual Meeting - 12/1/2018

Press Mentions

The Economic Effects of the Coronavirus May Kill More Americans Than the Virus ItselfJanuary 25th, 2021
Administered Earlier, Cilta-Cel CAR T Produces Deep, Durable Responses in Multiple Myeloma PatientsDecember 9th, 2023